CHIODO, TIZIANA,HAFNER, ANDREAS,HINTERMANN, TOBIAS,SALVADOR, BEATE,SZELAGIEWICZ, MARTIN,BLATTER, FRITZ,SIEBENHAAR, BERND,VOSSEN, MARCUS
申请号：
EP13804937
公开号：
EP2861589A4
申请日:
2013.06.13
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
Provided are a multicomponent crystalline system (co-crystal), use thereof, as well as a process for obtaining the same. The said multicomponent crystalline system (co-crystal) comprises Dasatinib and a second compound selected from methyM-hydrobenzoate, nicotinamide, ethyl gallate, methyl gallate, propyl gallate, ethyl maltol, vanillin, menthol, or (1R,2S,5R)-(&minus)-menthol.
